Skip to content

Arvinas ARVN Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.98M-44.4%
Immunome logo
ImmunomeIMNM
$0-100%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M-25.0%
Enliven Therapeutics logo
Enliven TherapeuticsELVN
-$266K-691%
Erasca, Inc. logo
Erasca, Inc.ERAS
$746K-62.4%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$1.21M-67.9%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Arvinas’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arvinas's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arvinas's accretion (amortization) of discounts and premiums, investments?
Arvinas (ARVN) reported accretion (amortization) of discounts and premiums, investments of $1.7M in Q1 2026.
How has Arvinas's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Arvinas's accretion (amortization) of discounts and premiums, investments decreased by 55.3% year-over-year, from $3.8M to $1.7M.
What is the long-term trend for Arvinas's accretion (amortization) of discounts and premiums, investments?
Over 3 years (2021 to 2025), Arvinas's accretion (amortization) of discounts and premiums, investments has grown at a 10.8% compound annual growth rate (CAGR), from -$9.4M to $12.8M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to interest income or expense resulting from the amortization of premiums or the accretion of discounts on debt or investment securities held by the company. It reflects the difference between the purchase price and the face value of financial instruments as they approach maturity. Investors use this to understand the underlying yield adjustments on the company's investment portfolio or debt obligations.